{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:33:43Z","timestamp":1789594423094,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T00:00:00Z","timestamp":1458000000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s11739-016-1427-5","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T16:28:16Z","timestamp":1458318496000},"page":"467-476","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of thromboprophylaxis with anticoagulant drugs on the incidence of arterial thrombotic events in medical inpatients: a systematic review"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5705-2897","authenticated-orcid":false,"given":"Alessandro","family":"Squizzato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Lussana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Ageno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,15]]},"reference":[{"key":"1427_CR1","doi-asserted-by":"crossref","first-page":"e195S","DOI":"10.1378\/chest.11-2296","volume":"141","author":"SR Kahn","year":"2012","unstructured":"Kahn SR, Lim W, Dunn AS et al (2012) Prevention of VTE in nonsurgical patients antithrombotic therapy and prevention of thrombosis: American College of chest physicians evidence-based clinical practice guidelines. Chest 141:e195S\u2013e226S","journal-title":"Chest"},{"key":"1427_CR2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.thromres.2014.06.027","volume":"134","author":"F Lussana","year":"2014","unstructured":"Lussana F, Squizzato A, Permunian ET, Cattaneo M (2014) A systematic review on the effect of aspirin in the prevention of post-operative arterial thrombosis in patients undergoing total hip and total knee arthroplasty. Thromb Res 134:599\u2013603","journal-title":"Thromb Res"},{"key":"1427_CR3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11739-014-1168-2","volume":"10","author":"DJF Stuijver","year":"2015","unstructured":"Stuijver DJF, Romualdi E, van Zaane B et al (2015) Under-reporting of venous and arterial thrombotic events in randomized clinical trials: a meta-analysis. Intern Emerg Med 10:219\u2013246","journal-title":"Intern Emerg Med"},{"key":"1427_CR4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/CIRCULATIONAHA.107.709204","volume":"117","author":"W Ageno","year":"2008","unstructured":"Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW (2008) Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 117:93\u2013102","journal-title":"Circulation"},{"key":"1427_CR5","first-page":"CD003747","volume":"5","author":"R Alikhan","year":"2014","unstructured":"Alikhan R, Bedenis R, Cohen AT (2014) Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction). Cochrane Database Syst Rev 5:CD003747","journal-title":"Cochrane Database Syst Rev"},{"issue":"264\u2013269","key":"1427_CR6","doi-asserted-by":"crossref","first-page":"W264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(264\u2013269):W264","journal-title":"Ann Intern Med"},{"key":"1427_CR7","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC et al (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928","journal-title":"BMJ"},{"key":"1427_CR8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177\u2013188","journal-title":"Control Clin Trials"},{"key":"1427_CR9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327:557\u2013560","journal-title":"BMJ"},{"key":"1427_CR10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/003693308102600205","volume":"26","author":"JJ Belch","year":"1981","unstructured":"Belch JJ, Lowe GD, Ward AG, Forbes CD, Prentice CR (1981) Prevention of deep vein thrombosis in medical patients by low-dose heparin. Scott Med J 26:115\u2013117","journal-title":"Scott Med J"},{"key":"1427_CR11","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJM197303152881103","volume":"288","author":"AS Gallus","year":"1973","unstructured":"Gallus AS, Hirsh J, Tutle RJ et al (1973) Small subcutaneous doses of heparin in prevention of venous thrombosis. N Engl J Med 288:545\u2013551","journal-title":"N Engl J Med"},{"key":"1427_CR12","first-page":"159","volume":"16","author":"R Dahan","year":"1986","unstructured":"Dahan R, Houlbert D, Caulin C et al (1986) Prevention of deep vein thrombosis in elderly medical in-patients by a low molecular weight heparin: a randomized double-blind trial. Haemostasis 16:159\u2013164","journal-title":"Haemostasis"},{"key":"1427_CR13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/000331978803900603","volume":"39","author":"C Ibarra-P\u00e9rez","year":"1988","unstructured":"Ibarra-P\u00e9rez C, Lau-Cort\u00e9s E, Colmenero-Zubiate S et al (1988) Prevalence and prevention of deep venous thrombosis of the lower extremities in high-risk pulmonary patients. Angiology 39:505\u2013513","journal-title":"Angiology"},{"key":"1427_CR14","first-page":"567","volume":"24","author":"B Forette","year":"1995","unstructured":"Forette B, Wolmark Y (1995) Calcium nadroparin in the prevention of thromboembolic disease in elderly subjects. Study of tolerance. Presse Med 24:567\u2013571","journal-title":"Presse Med"},{"key":"1427_CR15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1055\/s-0038-1650617","volume":"76","author":"JF Bergmann","year":"1996","unstructured":"Bergmann JF, Neuhart E (1996) A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group. Thromb Haemost 76:529\u2013534","journal-title":"Thromb Haemost"},{"key":"1427_CR16","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(96)91009-0","volume":"347","author":"B G\u00e4rdlund","year":"1996","unstructured":"G\u00e4rdlund B (1996) Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. The Heparin Prophylaxis Study Group. Lancet 347:1357\u20131361","journal-title":"Lancet"},{"issue":"Suppl 2","key":"1427_CR17","first-page":"49","volume":"26","author":"E Lechler","year":"1996","unstructured":"Lechler E, Schramm W, Flosbach CW (1996) The venous thrombotic risk in non-surgical patients: epidemiological data and efficacy\/safety profile of a low-molecular-weight heparin (enoxaparin). The Prime Study Group. Haemostasis 26(Suppl 2):49\u201356","journal-title":"Haemostasis"},{"key":"1427_CR18","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","volume":"341","author":"MM Samama","year":"1999","unstructured":"Samama MM, Cohen AT, Darmon JY et al (1999) A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med 341:793\u2013800","journal-title":"N Engl J Med"},{"key":"1427_CR19","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1164\/ajrccm.161.4.9807025","volume":"161","author":"F Fraisse","year":"2000","unstructured":"Fraisse F, Holzapfel L, Couland JM et al (2000) Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The Association of Non-University Affiliated intensive care specialist physicians of France. Am J Respir Crit Care Med 161:1109\u20131114","journal-title":"Am J Respir Crit Care Med"},{"key":"1427_CR20","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1067\/mhj.2003.189","volume":"145","author":"FX Kleber","year":"2003","unstructured":"Kleber FX, Witt C, Vogel G, THE-PRINCE Study Group (2003) Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease. Am Heart J 145:614\u2013621","journal-title":"Am Heart J"},{"key":"1427_CR21","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.0000138928.83266.24","volume":"110","author":"A Leizorovicz","year":"2004","unstructured":"Leizorovicz A, Cohen AT, Turpie AG, PREVENT Medical Thromboprophylaxis Study Group (2004) Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 110:874\u2013879","journal-title":"Circulation"},{"key":"1427_CR22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00228-005-0944-3","volume":"61","author":"I Mah\u00e9","year":"2005","unstructured":"Mah\u00e9 I, Bergmann JF, d\u2019Az\u00e9mar P, Vaissie JJ, Caulin C (2005) Lack of effect of a low-molecular-weight heparin (nadroparin) on mortality in bedridden medical in-patients: a prospective randomised double-blind study. Eur J Clin Pharmacol 61:347\u2013351","journal-title":"Eur J Clin Pharmacol"},{"key":"1427_CR23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.amjmed.2005.03.049","volume":"119","author":"FA Lederle","year":"2006","unstructured":"Lederle FA, Sacks JM, Fiore L et al (2006) The prophylaxis of medical patients for thromboembolism pilot study. Am J Med 119:54\u201359","journal-title":"Am J Med"},{"key":"1427_CR24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/bmj.38733.466748.7C","volume":"332","author":"AT Cohen","year":"2006","unstructured":"Cohen AT, Davidson BL, Gallus AS, ARTEMIS Investigators et al (2006) Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ 332:325\u2013329","journal-title":"BMJ"},{"key":"1427_CR25","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1517\/14656566.2010.521498","volume":"11","author":"SM Schellong","year":"2010","unstructured":"Schellong SM, Haas S, Greinacher A et al (2010) An open-label comparison of the efficacy and safety of certoparin versus unfractionated heparin for the prevention of thromboembolic complications in acutely ill medical patients: certain. Expert Opin Pharmacother 11:2953\u20132961","journal-title":"Expert Opin Pharmacother"},{"key":"1427_CR26","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/j.1538-7836.2010.03848.x","volume":"8","author":"H Riess","year":"2010","unstructured":"Riess H, Haas S, Tebbe U et al (2010) A randomized, double-blind study of certoparin vs. unfractionated heparin to prevent venous thromboembolic events in acutely ill, non-surgical patients: CERTIFY Study. J Thromb Haemost 8:1209\u20131215","journal-title":"J Thromb Haemost"},{"key":"1427_CR27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7326\/0003-4819-153-1-201007060-00004","volume":"153","author":"RD Hull","year":"2010","unstructured":"Hull RD, Schellong SM, Tapson VF, for the EXCLAIM (Extended Prophylaxis for venous thrombo embolism in acutely ill medical patients with prolonged immobilization) Study et al (2010) Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial. Ann Intern Med 153:8\u201318","journal-title":"Ann Intern Med"},{"key":"1427_CR28","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1056\/NEJMoa1111288","volume":"365","author":"AK Kakkar","year":"2011","unstructured":"Kakkar AK, Cimminiello C, Goldhaber SZ, for the LIFENOX Investigators et al (2011) Low molecular weight heparin and mortality in acutely ill medical patients. N Engl J Med 365:2463\u20132472","journal-title":"N Engl J Med"},{"key":"1427_CR29","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMoa1110899","volume":"365","author":"SZ Goldhaber","year":"2011","unstructured":"Goldhaber SZ, Leizorovicz A, Kakkar AK, ADOPT Trial Investigators et al (2011) Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. N Engl J Med 365:2167\u20132177","journal-title":"N Engl J Med"},{"key":"1427_CR30","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1111096","volume":"368","author":"AT Cohen","year":"2013","unstructured":"Cohen AT, Spiro TE, B\u00fcller HR, MAGELLAN Investigators et al (2013) Rivaroxaban for thromboprophylaxis in acutely ill medical patients. N Engl J Med 368:513\u2013523","journal-title":"N Engl J Med"},{"key":"1427_CR31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archinternmed.2011.1666","volume":"172","author":"K Uchino","year":"2012","unstructured":"Uchino K, Hernandez AV (2012) Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials. Arch Intern Med 172:397\u2013402","journal-title":"Arch Intern Med"},{"key":"1427_CR32","unstructured":"A study of rivaroxaban (JNJ-39039039) on the venous thromboembolic risk in post-hospital discharge patients (MARINER). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02111564"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-016-1427-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-016-1427-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-016-1427-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T09:42:57Z","timestamp":1600335777000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-016-1427-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,15]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["1427"],"URL":"https:\/\/doi.org\/10.1007\/s11739-016-1427-5","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,15]]}}}